RESEARCHER PROFILE

Demetres D. Leonidas

← Back to University of Thessaly

D

University of Thessaly

Enzyme Structure and FunctionGlycogen Storage Diseases and MyoclonusCarbohydrate Chemistry and SynthesisBiochemical and Molecular ResearchProtein Structure and Dynamics

Demetres D. Leonidas works in Enzyme Structure and Function, Glycogen Storage Diseases and Myoclonus, Carbohydrate Chemistry and Synthesis, Biochemical and Molecular Research, Protein Structure and Dynamics. Recorded institutional associations include University of Thessaly.

285Publications
4,178Citations
36H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Naturally Occurring Pentacyclic Triterpenes as Inhibitors of Glycogen Phosphorylase: Synthesis, Structure−Activity Relationships, and X-ray Crystallographic Studies

    2008 · 191 citations
  2. Structural Basis for the Recognition of Carbohydrates by Human Galectin-7,

    1998 · 190 citations
  3. Crystal structure of human Charcot–Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins

    1995 · 154 citations
  4. New Inhibitors of Glycogen Phosphorylase as Potential Antidiabetic Agents

    2008 · 143 citations
  5. Charcot-Leyden Crystal Protein (Galectin-10) Is Not a Dual Function Galectin with Lysophospholipase Activity but Binds a Lysophospholipase Inhibitor in a Novel Structural Fashion

    2002 · 121 citations
  6. Design of Inhibitors of Glycogen Phosphorylase: A Study of .alpha.- and .beta.-C-Glucosides and 1-Thio-.beta.-D-glucose Compounds

    1994 · 119 citations
  7. Anopheles gambiae odorant binding protein crystal complex with the synthetic repellent DEET: implications for structure-based design of novel mosquito repellents

    2011 · 114 citations
  8. Selective Recognition of Mannose by the Human Eosinophil Charcot-Leyden Crystal Protein (Galectin-10): A Crystallographic Study at 1.8 Å Resolution,

    1999 · 110 citations
  9. The Crystal Structure of Human Placenta Growth Factor-1 (PlGF-1), an Angiogenic Protein, at 2.0 Å Resolution

    2001 · 110 citations
  10. Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications

    2020 · 97 citations
  11. Refined Crystal Structures of Native Human Angiogenin and Two Active Site Variants: Implications for the Unique Functional Properties of an Enzyme Involved in Neovascularisation During Tumour Growth

    1999 · 90 citations
  12. Kinetic and crystallographic studies on 2‐(β‐D‐glucopyranosyl)‐5‐methyl‐1, 3, 4‐oxadiazole, ‐benzothiazole, and ‐benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site

    2005 · 89 citations
  13. Crystal Structures of Ribonuclease A Complexes with 5‘-Diphosphoadenosine 3‘-Phosphate and 5‘-Diphosphoadenosine 2‘-Phosphate at 1.7 Å Resolution,

    1997 · 80 citations
  14. The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor

    1997 · 77 citations
  15. Natural products and their derivatives as inhibitors of glycogen phosphorylase: potential treatment for type 2 diabetes

    2014 · 73 citations
  16. Amide-1,2,3-triazole bioisosterism: the glycogen phosphorylase case

    2009 · 72 citations
  17. Binding of N‐acetyl‐N ′‐β‐ d ‐glucopyranosyl urea and N‐benzoyl‐N ′‐β‐ d ‐glucopyranosyl urea to glycogen phosphorylase b

    2002 · 69 citations
  18. Crystal Structure of Eosinophil Cationic Protein at 2.4 Å Resolution,

    1999 · 66 citations
  19. Iminosugars as Potential Inhibitors of Glycogenolysis: Structural Insights into the Molecular Basis of Glycogen Phosphorylase Inhibition

    2006 · 65 citations
  20. Glucose-based spiro-isoxazolines: A new family of potent glycogen phosphorylase inhibitors

    2009 · 62 citations
  21. Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions

    2020 · 62 citations
  22. High‐resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure‐based design of ribonucleolytic inhibitors

    2003 · 56 citations
  23. Crystal Structure of the Eosinophil Major Basic Protein at 1.8 Å

    2001 · 53 citations
  24. Mapping the Ribonucleolytic Active Site of Eosinophil-derived Neurotoxin (EDN)

    2001 · 47 citations
  25. Toward Rational Design of Ribonuclease Inhibitors: High-Resolution Crystal Structure of a Ribonuclease A Complex with a Potent 3‘,5‘-Pyrophosphate-Linked Dinucleotide Inhibitor,

    1999 · 46 citations

← Return to the university profile